|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.24 CAD | +9.09% |
|
+4.35% | +9.09% |
| 04-05 | NexgenRx Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | NEXGENRX INC. Announces the Retirement of Dave Bennett from its Board of Directors | CI |
NexgenRx Inc. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported revenue was CAD 11.84 million compared to CAD 11.04 million a year ago. Net income was CAD 4.02 million compared to CAD 2.12 million a year ago.
Basic earnings per share from continuing operations was CAD 0.057 compared to CAD 0.03 a year ago. Diluted earnings per share from continuing operations was CAD 0.054 compared to CAD 0.029 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +9.09% | 12.5M | |
| -0.50% | 120B | |
| +5.06% | 97.17B | |
| +14.36% | 69.14B | |
| +23.75% | 64.14B | |
| +12.91% | 43.95B | |
| +14.78% | 43.3B | |
| +22.97% | 36.38B | |
| +7.83% | 25.91B | |
| +0.18% | 23.39B |
NEXGENRX INC. 
